EFFECTS OF VALPROATE IN A MODEL NERVOUS-SYSTEM (BUCCAL GANGLIA OF HELIX-POMATIA) .1. ANTIEPILEPTIC ACTIONS

被引:33
作者
ALTRUP, U
GERLACH, G
REITH, H
SAID, MN
SPECKMANN, EJ
机构
[1] DESITIN ARZNEIMITTEL GMBH,HAMBURG,GERMANY
[2] INST PHYSIOL,MUNSTER,GERMANY
关键词
ANTICONVULSANTS; VALPROATE; TRANS-2-EN-VALPROATE; PENTYLENETETRAZOL; ETOMIDATE; HELIX-POMATIA; NEUROLOGIC MODELS;
D O I
10.1111/j.1528-1157.1992.tb02356.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cellular actions of valproate (VPA) were studied using intracellular recordings of identified neuronal individuals in the buccal ganglia of Helix pomatia. Under nonepileptic conditions, VPA induced (a) a hyperpolarization, (b) slight changes in action potentials (AP), and (c) an increase in membrane resistance. Under epileptic conditions (i.e., during application of an epileptogenic drug), extracellular application of VPA decreased frequency of occurrence of epileptic depolarizations (early effect) and led to a decay in paroxysmal depolarizations (late effect). Intracellular injection of VPA could block epileptic activity in the treated neuron immediately. A metabolite of VPA (trans-2-en VPA) mainly lacked the late effect (decay in epileptic depolarizations) obtained with VPA. Results suggest that the early antiepileptic effect is exerted from the extracellular side of the neuronal membrane and that the late effect results from intracellular actions of VPA being delayed by slow access to an intracellular site.
引用
收藏
页码:743 / 752
页数:10
相关论文
共 31 条
[1]   EFFECTS OF THE HYPNOTIC DRUG ETOMIDATE IN A MODEL NERVOUS-SYSTEM (BUCCAL GANGLIA, HELIX-POMATIA) [J].
ALTRUP, U ;
LEHMENKUHLER, A ;
SPECKMANN, EJ .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1991, 99 (03) :579-587
[2]   MORPHOLOGY AND FUNCTION OF THE IDENTIFIED NEURON B3 IN THE BUCCAL GANGLIA OF HELIX-POMATIA [J].
ALTRUP, U ;
LEHMENKUHLER, A ;
MADEJA, M ;
SPECKMANN, EJ .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 1990, 97 (01) :65-74
[4]  
ALTRUP U, 1992, EPILEPSIA, V33, P751
[5]   SODIUM DI-N-PROPYLACETATE (VALPROATE) ACTION ON SINGLE NEURONS IN RAT CEREBRAL-CORTEX AND HIPPOCAMPUS [J].
BLUME, HW ;
LAMOUR, Y ;
ARNAULD, E ;
LAYTON, BS ;
RENAUD, LP .
BRAIN RESEARCH, 1979, 171 (01) :182-185
[6]   VALPROATE METABOLITE CONCENTRATIONS IN BRAIN INCREASE WITH CHRONIC ADMINISTRATION OF SODIUM VALPROATE [J].
CARL, GF ;
DELOACH, C ;
PATTERSON, J .
LIFE SCIENCES, 1985, 37 (21) :2029-2035
[7]   MECHANISM OF ANTI-CONVULSANT ACTION OF VALPROATE [J].
CHAPMAN, A ;
KEANE, PE ;
MELDRUM, BS ;
SIMIAND, J ;
VERNIERES, JC .
PROGRESS IN NEUROBIOLOGY, 1982, 19 (04) :315-359
[8]   NEUROPHYSIOLOGICAL AND BIOCHEMICAL-CHANGES EVOKED BY VALPROIC ACID IN THE CENTRAL-NERVOUS-SYSTEM [J].
COTARIU, D ;
ZAIDMAN, JL ;
EVANS, S .
PROGRESS IN NEUROBIOLOGY, 1990, 34 (04) :343-354
[9]  
HOJA L, 1985, EPILEPSIE, V83, P162
[10]  
KEANE PE, 1985, METHOD FIND EXP CLIN, V7, P83